Table of Contents

Articles

• You have access

  Quantitative Investigation of the Impact of P-Glycoprotein Inhibition on Drug Transport across Blood-Brain Barrier in Rats

  Hiroshi Sugimoto, Hideki Hirabayashi, Yoshiaki Kimura, Atsutoshi Furuta, Nobuyuki Amano and Toshiya Moriwaki

  Drug Metabolism and Disposition January 2011, 39 (1) 8-14; DOI: https://doi.org/10.1124/dmd.110.035774
• You have access

  Whole-Body Physiologically Based Pharmacokinetic Model for Nutlin-3a in Mice after Intravenous and Oral Administration

  Fan Zhang, Michael Tagen, Stacy Throm, Jeremy Mallari, Laura Miller, R. Kiplin Guy, Michael A. Dyer, Richard T. Williams, Martine F. Roussel, Katie Nemeth, Fangyi Zhu, Jiakun Zhang, Min Lu, John C. Panetta, Nidal Boulos and Clinton F. Stewart

  Drug Metabolism and Disposition January 2011, 39 (1) 15-21; DOI: https://doi.org/10.1124/dmd.110.035915
• You have access

  Activation of the Acute Inflammatory Response Alters Cytochrome P450 Expression and Eicosanoid Metabolism

  Katherine N. Theken, Yangmei Deng, M. Alison Kannon, Tricia M. Miller, Samuel M. Poloyac and Craig R. Lee

  Drug Metabolism and Disposition January 2011, 39 (1) 22-29; DOI: https://doi.org/10.1124/dmd.110.035287
• You have access

  Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist

  Anima Ghosal, Xiaowen Lu, Natalia Penner, Lan Gao, Ragu Ramanathan, Swapan K. Chowdhury, Narendra S. Kishnani and Kevin B. Alton

  Drug Metabolism and Disposition January 2011, 39 (1) 30-38; DOI: https://doi.org/10.1124/dmd.110.035493
• You have access

  Inhibition of Human Sterol Δ⁷-Reductase and Other Postlanosterol Enzymes by LK-980, a Novel Inhibitor of Cholesterol Synthesis

  Jure Ačimovič, Tina Korošec, Matej Seliškar, Ingemar Bjorkhem, Katalin Monostory, Pal Szabo, Jean-Marc Pascussi, Ales Belič, Uroš Urleb, Darko Kocjan and Damjana Rozman

  Drug Metabolism and Disposition January 2011, 39 (1) 39-46; DOI: https://doi.org/10.1124/dmd.110.035840
• You have access

  Characterization of Digoxin Uptake in Sandwich-Cultured Human Hepatocytes

  Emi Kimoto, Jonathan Chupka, Yongling Xiao, Yi-an Bi and David B. Duignan

  Drug Metabolism and Disposition January 2011, 39 (1) 47-53; DOI: https://doi.org/10.1124/dmd.110.034298
• You have access

  Toxicological Evaluation of Acyl Glucuronides of Nonsteroidal Anti-Inflammatory Drugs Using Human Embryonic Kidney 293 Cells Stably Expressing Human UDP-Glucuronosyltransferase and Human Hepatocytes

  Toshihisa Koga, Ryoichi Fujiwara, Miki Nakajima and Tsuyoshi Yokoi

  Drug Metabolism and Disposition January 2011, 39 (1) 54-60; DOI: https://doi.org/10.1124/dmd.110.035600
• You have access

  A Baeyer-Villiger Oxidation Specifically Catalyzed by Human Flavin-Containing Monooxygenase 5

  W. George Lai, Nadia Farah, George A. Moniz and Y. Nancy Wong

  Drug Metabolism and Disposition January 2011, 39 (1) 61-70; DOI: https://doi.org/10.1124/dmd.110.035360
• You have access

  Brain-Penetrating Tumor Necrosis Factor Decoy Receptor in the Mouse

  Qing-Hui Zhou, Ruben J. Boado, Eric Ka-Wai Hui, Jeff Zhiqiang Lu and William M. Pardridge

  Drug Metabolism and Disposition January 2011, 39 (1) 71-76; DOI: https://doi.org/10.1124/dmd.110.036012
• You have access

  Histone Deacetylase Inhibitors Increase Human Arylamine N-Acetyltransferase-1 Expression in Human Tumor Cells

  Scott Paterson, Kok L. Sin, Jacky M. Tiang, Rodney F. Minchin and Neville J. Butcher

  Drug Metabolism and Disposition January 2011, 39 (1) 77-82; DOI: https://doi.org/10.1124/dmd.110.036202
• You have access

  The Aryl Hydrocarbon Receptor Pathway and the Response to 3-Methylcholanthrene Are Altered in the Liver of Adrenalectomized Rats

  Anne K. Mullen Grey and David S. Riddick

  Drug Metabolism and Disposition January 2011, 39 (1) 83-91; DOI: https://doi.org/10.1124/dmd.110.035584
• You have access

  Effects of Pregnane X Receptor (NR1I2) and CYP2B6 Genetic Polymorphisms on the Induction of Bupropion Hydroxylation by Rifampin

  Jae Yong Chung, Joo-Youn Cho, Hyeong-Seok Lim, Jung-Ryul Kim, Kyung-Sang Yu, Kyoung Soo Lim, Sang-Goo Shin and In-Jin Jang

  Drug Metabolism and Disposition January 2011, 39 (1) 92-97; DOI: https://doi.org/10.1124/dmd.110.035246
• You have access

  In Vitro Cytochrome P450-Mediated Metabolism of Exemestane

  Landry K. Kamdem, David A. Flockhart and Zeruesenay Desta

  Drug Metabolism and Disposition January 2011, 39 (1) 98-105; DOI: https://doi.org/10.1124/dmd.110.032276
• You have access

  Application of Quantitative NMR in Pharmacological Evaluation of Biologically Generated Metabolites: Implications in Drug Discovery

  Abdul Mutlib, Robert Espina, Karthick Vishwanathan, Kathlene Babalola, Zecheng Chen, Christoph Dehnhardt, Aranapakam Venkatesan, Tarek Mansour, Inder Chaudhary, Rasmy Talaat and JoAnn Scatina

  Drug Metabolism and Disposition January 2011, 39 (1) 106-116; DOI: https://doi.org/10.1124/dmd.110.032490
• You have access

  Organic Cation Transporter-Mediated Renal Secretion of Ipratropium and Tiotropium in Rats and Humans

  Takeo Nakanishi, Tsunemitsu Haruta, Yoshiyuki Shirasaka and Ikumi Tamai

  Drug Metabolism and Disposition January 2011, 39 (1) 117-122; DOI: https://doi.org/10.1124/dmd.110.035402
• You have access

  Plasma Stability-Dependent Circulation of Acyl Glucuronide Metabolites in Humans: How Circulating Metabolite Profiles of Muraglitazar and Peliglitazar Can Lead to Misleading Risk Assessment

  Donglu Zhang, Nirmala Raghavan, Lifei Wang, Yongjun Xue, Mary Obermeier, Stephanie Chen, Shiwei Tao, Hao Zhang, Peter T. Cheng, Wenying Li, Ragu Ramanathan, Zheng Yang and W. Griffith Humphreys

  Drug Metabolism and Disposition January 2011, 39 (1) 123-131; DOI: https://doi.org/10.1124/dmd.110.035048
• You have access

  Drug Efflux Transporter Multidrug Resistance-Associated Protein 5 Affects Sensitivity of Pancreatic Cancer Cell Lines to the Nucleoside Anticancer Drug 5-Fluorouracil

  Praveen K. Nambaru, Tobias Hübner, Kathleen Köck, Steffen Mews, Markus Grube, Léa Payen, Jérôme Guitton, Matthias Sendler, Gabriele Jedlitschky, Christian Rimmbach, Dieter Rosskopf, Dariusz W. Kowalczyk, Heyo K. Kroemer, Frank U. Weiss, Julia Mayerle, Markus M. Lerch and Christoph A. Ritter

  Drug Metabolism and Disposition January 2011, 39 (1) 132-139; DOI: https://doi.org/10.1124/dmd.110.033613
• You have access

  Generation of Human Chiral Metabolites of Simvastatin and Lovastatin by Bacterial CYP102A1 Mutants

  Keon-Hee Kim, Ji-Yeon Kang, Dong-Hyun Kim, Sun-Ha Park, Seon Ha Park, Dooil Kim, Ki Deok Park, Young Ju Lee, Heung-Chae Jung, Jae-Gu Pan, Taeho Ahn and Chul-Ho Yun

  Drug Metabolism and Disposition January 2011, 39 (1) 140-150; DOI: https://doi.org/10.1124/dmd.110.036392
• You have access

  Identification of Clinically Used Drugs That Activate Pregnane X Receptors

  Sunita J. Shukla, Srilatha Sakamuru, Ruili Huang, Timothy A. Moeller, Paul Shinn, Danielle VanLeer, Douglas S. Auld, Christopher P. Austin and Menghang Xia

  Drug Metabolism and Disposition January 2011, 39 (1) 151-159; DOI: https://doi.org/10.1124/dmd.110.035105